| 12.4°C Dublin

Close

Premium

Glanbia's Performance Nutrition woes make unit ripe for a sale

Close

Albert Manifold, CEO of CRH. Photo: Gary O' Neill

Albert Manifold, CEO of CRH. Photo: Gary O' Neill

Albert Manifold, CEO of CRH. Photo: Gary O' Neill

Glanbia issued several profit warnings in 2019, with the share price tumbling more than 40pc since this time last year. Chief executive Siobhán Talbot blamed everything from international supply chain issues to tariffs and "geopolitical tension".

But last week, the company homed in on Glanbia Performance Nutrition (GPN) as the central problem facing the group.

There are some fundamental issues with Glanbia's one-time wonder division GPN, namely that whey protein is not now viewed as the super-supplement for fitness and health that it was once believed to be.